首页> 中文期刊> 《山西医科大学学报》 >受人E2F1启动子调控的条件复制型腺病毒载体的构建与鉴定

受人E2F1启动子调控的条件复制型腺病毒载体的构建与鉴定

         

摘要

目的 构建并鉴定受人E2F1基因启动子调控的条件复制型腺病毒载体.方法 以人胚肾293细胞的基因组DNA为模板,PCR扩增E2F1基因启动子调控序列,构建表达质粒pE2F1 p-EGFP;PCR扩增腺病毒早期基因E1A,构建表达质粒pTERT p-E1A;将重组质粒pTERT p-E1A酶切得到的E1A基因,插入线性化的pE2F1 p-EGFP,构建pE2F1 p-E1A;酶切重组质粒pE2F1 p-E1A产生受E2F1基因启动子调控E1A的完整表达框,插入质粒pDC311中,构建腺病毒包装穿梭质粒pDC311-E2F1 p-E1A,与腺病毒骨架质粒pBHGlox△1,3Cre共转染人胚肾293细胞,得到条件复制型腺病毒Ad-E2F1 p-E1A;扩增病毒并分别感染E2F1活性增强的系列肿瘤细胞株,利用病毒空斑形成实验检测重组条件复制型病毒的条件复制能力.结果 限制性内切酶鉴定显示重组质粒构建成功,受人E2F1基因启动子调控的溶瘤腺病毒载体仅在E2F1活性增强的肿瘤细胞株中实现条件性复制.结论 构建的新型条件复制型腺病毒载体具有良好的选择性复制能力,在E2F1活性增强的肿瘤治疗方面有良好的应用前景.%Objective To construct and identify a conditionally replicative adenovirus ( CRAd ) regulated by E2F1 gene promoter. Methods Human E2F1 gene promoter and adenoviral E1A gene were amplified by PCR using the genomic DNA of human embryo kidney cells AD-293 as a template. The fragment of human E2F1 gene promoter was digested and then inserted into pEGFP-1 for cons-tructing pE2Fl p-EGFP. The open read frame sequence of El A was digested and then cloned into pTERT promoter-EGFP to obtain pTERT p-ElA. The E1A gene was digested from recombinant pTERT p-ElA plasmid and inserted into linearized pE2Fl p-EGFP to obtain pE2Fl p-ElA. The expression cassette of E1A gene under the control of E2F1 promoter was digested from recombinant pE2Fl p-E1A plasmid and cloned into shuttle vector pDC311. The pDC311-E2Fl p-ElA plasmid was cotransfected with adenoviral genomic plasmid pBHGlox△l ,3Cre into AD-293 cells to package the recombinant adenovirus Ad-E2F1 p-ElA. The Ad-E2F1 p-ElA vector was amplified and its selective replication ability was evaluated by plaque forming assay in cancer cells overexpressing E2F-1 protein. Results Positive recombinant plasmid was confirmed by restriction enzyme digestion. Ad-E2F1 p-ElA vector was successfully constructed, which could selectively replicate in E2F1 positive cancer cells. Conclusion The constructed Ad-E2F1 p-ElA in tumor cells has a good ability of selective replication, and emerge an innovative promising application in the treatment of E2F1 positive cancers.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号